Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
05/28/2014 | CN103816438A 一种制备清糖胶囊的配方及方法 A clear sugar capsule formulation and method of preparation |
05/28/2014 | CN103816428A 一种有效治疗糖尿病的制剂 An effective therapeutic agents for diabetes |
05/28/2014 | CN103816408A 一种用于糖尿病的中药 Chinese medicine for diabetes |
05/28/2014 | CN103816389A 一种增强人体免疫力的铁皮石斛保健品 An enhanced human immunity Dendrobium health products |
05/28/2014 | CN103816340A 一种治疗高血脂的中药汤剂 A treatment for high cholesterol decoction |
05/28/2014 | CN103816310A 一种中药降脂茶 A traditional Chinese medicine Fat Tea |
05/28/2014 | CN103816291A 一种乌龙茶艾草泡脚粉及其制备方法 One kind of wormwood tea foot bath powder and its preparation method |
05/28/2014 | CN103816278A 一种用于降低血糖的组合物及其应用 A method for reducing blood sugar composition and Applications |
05/28/2014 | CN103816213A 一种从紫穗槐根中提取药物组合物的制备方法及新医药用途 An extraction method for the preparation of pharmaceutical compositions and new medicine uses the roots from amorpha |
05/28/2014 | CN103816212A 一种降低血糖的醋泡豆药物及其制备方法 Vinegar soak beans a drug to lower blood sugar and its preparation method |
05/28/2014 | CN103816207A 一种绞股蓝皂苷长循环脂质体制剂及其制备方法 One kind of saponin long-circulating liposome formulation and preparation method Gynostemma |
05/28/2014 | CN103816195A 西洋参皂苷注射剂及其制备方法 American ginseng saponin injection and preparation method |
05/28/2014 | CN103816162A 泽泻醇a 23-乙酸酯在制备治疗肥胖病药物中的应用 Alisol a 23- acetate in the manufacture of a medicament for the treatment of obesity Application |
05/28/2014 | CN103816161A 泽泻醇a 24-乙酸酯在制备防治肥胖病药物中的应用 Alisol a 24- acetate in the manufacture of a medicament for the prevention and treatment of obesity |
05/28/2014 | CN103816158A 用于治疗fab-相关疾病的嘌呤衍生物 For the treatment of a disease associated with a purine derivative fab- |
05/28/2014 | CN103816153A 化合物dzcy06在制备治疗糖尿病药物中的用途 Dzcy06 compound in the manufacture of a medicament for the treatment of diabetes |
05/28/2014 | CN103816147A 藤黄酸、新藤黄酸及其组合物的医药新用途 Pharmaceutical new uses GA, GA and new compositions |
05/28/2014 | CN103816141A 一种使鲍鱼苗自然脱落的麻醉剂及其使用方法 One kind of abalone seedlings so that the natural shedding of anesthetic and method of use |
05/28/2014 | CN103816130A 一种盐酸二甲双胍缓释片 One kind of metformin hydrochloride sustained-release tablets |
05/28/2014 | CN103816119A 制备维生素k1乳剂的方法和维生素k1乳剂 Method for preparing an emulsion of vitamin and vitamin k1 k1 emulsions |
05/28/2014 | CN103816117A 一种琥珀布考纳米混悬液及其制备方法 An amber nanosuspension cloth exam and its preparation method |
05/28/2014 | CN103816112A 一种复方丹参凝胶剂的制备方法 A method for the preparation of Compound Salvia gels |
05/28/2014 | CN103816072A 一种植物精粹窈窕纤体霜 A plant essence slim slimming cream |
05/28/2014 | CN103815714A 颈椎保健枕 Cervical Pillow |
05/28/2014 | CN103815395A 蜂胶与红花籽油软胶囊及其制备方法 Propolis and safflower seed oil soft capsule and its preparation method |
05/28/2014 | CN103815306A 一种适于糖尿病患者的保健食品 One kind of health food products suitable for diabetics |
05/28/2014 | CN103815097A 一种玫瑰花茶组合物及其制备方法 One kind of tea roses composition and its preparation method |
05/28/2014 | CN103815080A 苦荞速溶茶及其制备方法 Buckwheat instant tea and its preparation method |
05/28/2014 | CN103251065B 家养梅花鹿鹿骨粉、其制备方法及由其制备的梅花鹿鹿骨咀嚼片 Domestic sika deer bone, its preparation method and prepared therefrom sika deer bone chewable tablets |
05/28/2014 | CN103212000B 一种治疗糖尿病患者创口不愈合药物的制备方法 A method of treating non-healing wounds in diabetic patients with drug preparation |
05/28/2014 | CN103204944B 用于治疗糖尿病的长效免疫融合蛋白 Long-lasting immunity fusion protein for the treatment of diabetes |
05/28/2014 | CN103142546B 骨化三醇胶囊及其制备方法 Calcitriol capsule and its preparation method |
05/28/2014 | CN103142502B 一种骨化三醇缓释颗粒及其制备方法 One kind of calcitriol release granules and its preparation method |
05/28/2014 | CN103142483B 苷糖酯干混悬剂及其制备方法 Glycoside sugar esters dry suspension and its preparation method |
05/28/2014 | CN103127380B 一种治疗由糖尿病引起的消渴症的复方制剂 A method of treating disease caused by diabetes Diabetes compound preparation |
05/28/2014 | CN103110807B 一种治疗糖尿病的药物 Drugs for treating diabetes |
05/28/2014 | CN103083582B 一种治疗高血脂的药物 A treatment for high cholesterol drug |
05/28/2014 | CN103083279B 藻酸双酯钠软胶囊 Alginic sodium diester soft capsules |
05/28/2014 | CN103012598B 用于治骨质疏松症和肥胖的OGP-rhLeptin融合蛋白及编码该融合蛋白的核酸 For nucleic acid treatment of osteoporosis and obesity OGP-rhLeptin fusion protein and encoding the fusion protein |
05/28/2014 | CN102973537B 治疗高胆固醇血症的普罗布考缓释胶囊及其生产方法 Treatment of hypercholesterolemia probucol release capsules and production methods |
05/28/2014 | CN102861135B 苦荞黄酮提取方法 Buckwheat Flavonoids Extraction Method |
05/28/2014 | CN102838651B 一类齐墩果酸的衍生物及其制备方法和用途 A class of oleanolic acid derivatives and their preparation and use |
05/28/2014 | CN102757334B 苯丁酸钠Ⅱ型晶体及其制备方法 Ⅱ type crystals of sodium phenylbutyrate and its preparation method |
05/28/2014 | CN102698101B 一种有良好管道流动性的鼻饲营养膳 A kind of good nutrition conduit liquidity nasogastric feeding |
05/28/2014 | CN102690259B 具有利尿作用的化合物、其制备方法和用途 Compounds having a diuretic effect, their preparation and use |
05/28/2014 | CN102688296B 一种具有降血脂作用的中药组合物及其制备方法和应用 Chinese medicine composition and its preparation method and application having effect on blood |
05/28/2014 | CN102659570B 二氟非诺贝特酸及其在药学上可接受的盐,以及它们的制备方法和应用 Fenofibric acid fluoride and its pharmaceutically acceptable salts thereof, and methods for their preparation and application |
05/28/2014 | CN102552247B 一种维生素c的组合物及其制备方法 Vitamin c composition and preparation method |
05/28/2014 | CN102481325B 用于预防或治疗由ampk的激活介导的与肥胖有关的疾病、且含有作为活性成分的2,5-二芳基-3,4-二甲基四氢呋喃木脂素的组合物 For the prevention or treatment of the ampk mediated activation of obesity-related diseases, and a composition containing as active ingredient 2,5-diaryl-3,4-dimethyl-tetrahydrofuran lignans |
05/28/2014 | CN102458428B Nfat信号抑制剂和钙调磷酸酶抑制剂 Nfat signaling inhibitors and calcineurin inhibitors |
05/28/2014 | CN102247572B 一种治疗高脂血症的药物 A method of treating hyperlipidemia drugs |
05/28/2014 | CN102133393B 稳定性提高的酸性胰岛素制剂 To improve the stability of acidic insulin preparations |
05/28/2014 | CN102015676B 作为amp-活化的蛋白激酶(ampk)活化剂的噻吩并吡啶酮衍生物 Thiophene amp- activated protein kinase (ampk) activator and pyridone derivative |
05/27/2014 | US8735447 Crystalline solids of a MetAP-2 inhibitor and methods of making and using same |
05/27/2014 | US8735364 Antisense modulation of apolipoprotein B expression |
05/27/2014 | US8735349 Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/L |
05/27/2014 | US8735348 Casein derived peptides and uses thereof |
05/27/2014 | US8735347 Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling |
05/27/2014 | CA2792234C 2,3 dihydro-1h-inden-1-yl-2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
05/27/2014 | CA2727634C Calcium fluoride phosphate complexes |
05/27/2014 | CA2726861C Devices, formulations, and methods for delivery of multiple beneficial agents |
05/27/2014 | CA2712614C Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
05/27/2014 | CA2699718C Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
05/27/2014 | CA2633243C Azepinoindole derivatives as pharmaceutical agents |
05/27/2014 | CA2621292C 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
05/27/2014 | CA2598087C 5-[4-(4-(2-amino-2 methoxycarbonylethyl)phenoxy)benzilidene]thiazolidin-2,4-dione derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
05/27/2014 | CA2460685C Cyclosporine analogue mixtures and their use as immunomodulating agents |
05/22/2014 | WO2014078611A1 Dihydropyrazole gpr40 modulators |
05/22/2014 | WO2014078610A1 Dihydropyrazole gpr40 modulators |
05/22/2014 | WO2014078609A1 Pyrrolidine gpr40 modulators |
05/22/2014 | WO2014078206A1 Allene derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
05/22/2014 | WO2014078200A1 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators |
05/22/2014 | WO2014078197A1 2-thio-1,3,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators |
05/22/2014 | WO2014077575A1 Agar-derived neoagarooligosaccharide composite composition prepared by daga enzyme reaction and having anti-obesity and anti-diabetes effects |
05/22/2014 | WO2014077532A1 Novel piperazine derivative, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating metabolic disorders |
05/22/2014 | WO2014077487A1 Composition comprising suaeda japonica for preventing or alleviating diabetes |
05/22/2014 | WO2014077426A1 Pharmaceutical composition and functional health food containing stranvaesia davidiana extract for preventing or treating diabetes complications |
05/22/2014 | WO2014077425A1 Pharmaceutical composition and functional health food containing paulownia extract for preventing or treating diabetes complications |
05/22/2014 | WO2014077424A1 Pharmaceutical composition and functional health food containing carpinus cordata extract for preventing or treating diabetes complications |
05/22/2014 | WO2014077285A1 Pyridine derivative |
05/22/2014 | WO2014077235A1 2-pyridone compound |
05/22/2014 | WO2014077135A1 Blood acetaldehyde level-reducing agent |
05/22/2014 | WO2014076312A1 Sulforaphane for treating or reducing insulin resistance of the liver |
05/22/2014 | WO2014076270A1 Soluble collagen vi for use in the treatment of hyperglycemia linked diseases and glucose transport disorders. pharmaceutical composition, method and use of a cell extracellular liquid medium for increasing glucose uptake |
05/22/2014 | WO2014076246A1 Use of akkermansia for treating metabolic disorders |
05/22/2014 | WO2014076196A1 Anti apob antisense conjugate compounds |
05/22/2014 | WO2014075745A1 Use of akkermansia for treating metabolic disorders |
05/22/2014 | WO2014075636A1 Certain dipeptidyl peptidase inhibitors |
05/22/2014 | WO2014075589A1 Mesenchymal stem cell injection, preparation method thereof, and application thereof in preparing diabetes drug |
05/22/2014 | WO2014075317A1 Certain dipeptidyl peptidase inhibitors |
05/22/2014 | US20140142077 Androgen pharmaceutical composition and method for treating depression |
05/22/2014 | US20140142026 Anti-Pathogen Treatments |
05/22/2014 | US20140141089 Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same |
05/21/2014 | EP2733141A1 Azabenzimidazole derivative having ampk-activating activity |
05/21/2014 | EP2731950A1 Azetidine derivatives for treatment of melanin related disorders |
05/21/2014 | EP2731944A1 Gpr 119 modulators |
05/21/2014 | EP2731932A1 Aminomethyl quinolone compounds |
05/21/2014 | EP2731676A1 Novel fxr (nr1h4) binding and activity modulating compounds |
05/21/2014 | EP2731593A2 A composition, device and method for delayed and sustained release of brain energy molecules |
05/21/2014 | EP2731438A1 Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |